Bausch + Lomb Corp. (BLCO) shares tumbled 6.34% in pre-market trading on Wednesday following the release of its disappointing first-quarter earnings report. The eye health company's results fell short of analyst expectations, prompting a sell-off among investors.
The company reported a quarterly loss of $0.07 per share, a stark contrast to the $0.03 per share profit analysts had forecast. This represents a significant downturn from the same period last year when Bausch + Lomb posted earnings of $0.07 per share. The dramatic 333.33% miss on earnings expectations likely contributed to the sharp decline in the stock's pre-market price.
While Bausch + Lomb's sales showed some growth, increasing 3.46% year-over-year to $1.14 billion, they still fell short of the $1.15 billion analyst consensus estimate. The slight miss on revenue, combined with the unexpected loss, paints a challenging picture for the company's current financial position and near-term outlook, which appears to have shaken investor confidence in the pre-market session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.